These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22247283)

  • 1. Different patterns of pulmonary vascular disease induced by type 1 diabetes and moderate hypoxia in rats.
    Moral-Sanz J; Lopez-Lopez JG; Menendez C; Moreno E; Barreira B; Morales-Cano D; Escolano L; Fernandez-Segoviano P; Villamor E; Cogolludo A; Perez-Vizcaino F; Moreno L
    Exp Physiol; 2012 May; 97(5):676-86. PubMed ID: 22247283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Normobaric Hypoxia Induces Pulmonary Hypertension in Rats: Role of NF-κB.
    Fan J; Fan X; Li Y; Ding L; Zheng Q; Guo J; Xia D; Xue F; Wang Y; Liu S; Gong Y
    High Alt Med Biol; 2016 Mar; 17(1):43-9. PubMed ID: 26788753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 diabetes-induced hyper-responsiveness to 5-hydroxytryptamine in rat pulmonary arteries via oxidative stress and induction of cyclooxygenase-2.
    Lopez-Lopez JG; Moral-Sanz J; Frazziano G; Gomez-Villalobos MJ; Moreno L; Menendez C; Flores-Hernandez J; Lorente JA; Cogolludo A; Perez-Vizcaino F
    J Pharmacol Exp Ther; 2011 Jul; 338(1):400-7. PubMed ID: 21521772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
    Li QF; Dai AG
    Chin Med J (Engl); 2004 Jul; 117(7):1023-8. PubMed ID: 15265376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
    J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
    Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
    Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
    Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
    Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.
    Brock M; Samillan VJ; Trenkmann M; Schwarzwald C; Ulrich S; Gay RE; Gassmann M; Ostergaard L; Gay S; Speich R; Huber LC
    Eur Heart J; 2014 Dec; 35(45):3203-11. PubMed ID: 22450430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide synthase of rats with hypoxia-induced pulmonary hypertension.
    Pan P; Zhang X; Qian H; Shi W; Wang J; Bo Y; Li W
    Exp Biol Med (Maywood); 2010 May; 235(5):642-8. PubMed ID: 20463305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
    Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL
    J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension.
    MacLean MR; Deuchar GA; Hicks MN; Morecroft I; Shen S; Sheward J; Colston J; Loughlin L; Nilsen M; Dempsie Y; Harmar A
    Circulation; 2004 May; 109(17):2150-5. PubMed ID: 15078799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice.
    Satoh K; Kagaya Y; Nakano M; Ito Y; Ohta J; Tada H; Karibe A; Minegishi N; Suzuki N; Yamamoto M; Ono M; Watanabe J; Shirato K; Ishii N; Sugamura K; Shimokawa H
    Circulation; 2006 Mar; 113(11):1442-50. PubMed ID: 16534010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of endothelin-1 in rats developing hypobaric hypoxia-induced pulmonary hypertension.
    Nakanishi K; Tajima F; Nakata Y; Osada H; Tachibana S; Kawai T; Torikata C; Suga T; Takishima K; Aurues T; Ikeda T
    Lab Invest; 1999 Nov; 79(11):1347-57. PubMed ID: 10576205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of pulmonary vascular remodelling following hypoxic exposure: no effect of infusion of atrial natriuretic factor and neutral endopeptidase inhibitor.
    Zhao L; Hughes JM; Winter RJ
    Cardiovasc Res; 1994 Apr; 28(4):519-23. PubMed ID: 8181040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
    Morecroft I; Dempsie Y; Bader M; Walther DJ; Kotnik K; Loughlin L; Nilsen M; MacLean MR
    Hypertension; 2007 Jan; 49(1):232-6. PubMed ID: 17130306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
    Huh JW; Kim SY; Lee JH; Lee YS
    Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoxia-inducible factor 1alpha regulates vascular endothelial growth factor's roles on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension].
    Li QF; Dai AG
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):174-8. PubMed ID: 15130328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats.
    Kim EK; Lee JH; Oh YM; Lee YS; Lee SD
    Respirology; 2010 May; 15(4):659-68. PubMed ID: 20546541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.